SCHEMBL113540

SCHEMBL113540

Cc1cc(C)n(C(C=O)N2CCN(c3ccccc3-c3cnc(Oc4ccccc4)nc3)CC2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 1/20 0.40
KCNH2 Q12809 1/20 0.40
HPGDS O60760 6/20 0.33
CYP1A2 P05177 5/20 0.32
ALDH1A1 P00352 5/20 0.32
TSHR P16473 4/20 0.32
MAPK1 P28482 3/20 0.32
USP2 O75604 4/20 0.32
CYP2C9 P11712 4/20 0.32
CYP3A4 P08684 3/20 0.32
DHFR P00374 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
CYP2C19 P33261 1/20 0.32
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
GAA P10253 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
HTR1A P08908 2/20 0.31
HTR7 P34969 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL113658 0.92 CXCR3 (0.36) CXCR3KCNH2HPGDSALDH1A1TSHR
SCHEMBL114268 0.90 CXCR3 (0.40) CXCR3KCNH2TSHRUSP2DHFR
SCHEMBL114135 0.88 CXCR3 (0.41) CXCR3KCNH2ALDH1A1SMN1; SMN2MEN1
SCHEMBL115477 0.88 CXCR3 (0.42) CXCR3KCNH2TSHRUSP2DHFR
SCHEMBL115833 0.86 CXCR3 (0.41) CXCR3KCNH2DHFR
SCHEMBL113252 0.85 CXCR3 (0.41) CXCR3KCNH2DHFRHTR7
SCHEMBL113986 0.84 CXCR3 (0.40) CXCR3KCNH2ALDH1A1DHFRHTR7
SCHEMBL113125 0.84 CXCR3 (0.40) CXCR3KCNH2ALDH1A1TSHRMAPK1
SCHEMBL113545 0.84 CXCR3 (0.42) CXCR3KCNH2DHFRHTR7
SCHEMBL114041 0.84 CXCR3 (0.39) CXCR3KCNH2ALDH1A1TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed